Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/8/23 20:32 | 11/8/23 | EVLO | Health | Drug | Pharmaceutical Preparations | Bodmer Mark | MA | O | CSO,P of | 3 | S.d | -33 | 2.51 | 0 | -13 | 26 | D | |||||||||||||||
11/8/23 20:32 | 11/8/23 | EVLO | Health | Drug | Pharmaceutical Preparations | McHale Duncan | MA | O | Chief Me | 3 | S.d | -36 | 2.68 | 0 | -13 | 17 | D | |||||||||||||||
11/8/23 20:31 | 11/8/23 | EVLO | Health | Drug | Pharmaceutical Preparations | Gill Simba | MA | DO | P,CEO | 3 | S.d | -11 | 4.45 | 0 | -3 | 18 | D | |||||||||||||||
11/8/23 20:31 | 11/8/23 | EVLO | Health | Drug | Pharmaceutical Preparations | Thorell Marella | MA | O | CFO | 3 | S.d | -21 | 2.68 | 0 | -8 | 22 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |